September 2017

The CDC reports that more than 30 million Americans have diabetes, and an analysis of new Gallup-Sharecare data on diabetes by occupation.

A GAO report faults CMS policy on durable medical equipment, and the diaTribe Foundation convenes a daylong session to guide the FDA on how future drugs and devices should be evaluated for measures beyond A1C.

Coverage of technology developments at the 77th Scientific Sessions of the American Diabetes Association (ADA) and the annual meeting of the American Association of Diabetes Educators (AADE).

Three physicians presented results of CANVAS and CANVAS-R, as well as other studies, and invited questions about the use of canagliflozin in primary care.

More acquisitions and partnerships in diabetes tech.

The growing importance of quality ratings will put pressure on hospitals to meet ADA standards for insulin therapy without added manpower.

Without digital health providers, Medicare's Diabetes Prevention Program could have a hard time reaching seniors in rural areas, where rates of the disease are approximately 17% higher, one leading provider argued recently.

UnitedHealthcare has not released numbers on how many patients are affected by its exclusivity deal with Medtronic. While the initial press stories criticizing the transaction have died down, a JDRF initiative calls on insurers to preserve patient choice.

Studies presented at the American Diabetes Association Scientific Sessions showed that patients being treated with the ITCA 650 were less likely to need to take additional therapy to control their diabetes.

The latest version of the free app offers patients a simple color-coding system to track their blood sugar status, as well as an easy way to share data with their physicians and perhaps their health plan.

An experienced market watcher who has diabetes predicts the key to success will come down to one factor: ease of use.

A multi-layered partnership with the American Association of Diabetes Educators is just one of the strategic steps in the past year for WellDoc, which offers a suite of digital diabetes products, including one with an insulin bolus calculator.

The chief medical officer of Omada Health discusses a transition from one of the world's largest pharmaceutical companies to a digital health provider, and from treating chronic disease to preventing it.